CClinicalTrials.gg
CompletedNCT01114646Updated Aug 7, 2018Results posted

Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty

An interventional study of Cemented Hip Hemiarthroplasty and VerSys Beaded FullCoat, Zimmer in Femoral Neck Fracture, sponsored by Hartford Hospital. Completed at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2018-08-07.

Sponsored by Hartford Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

Hemiarthroplasty (half of a hip replacement) is the most common treatment for displaced fractures of the femoral neck in the elderly and is associated with a better functional outcome and fewer reoperations than internal fixation. Currently, the operative management of displaced femoral neck fractures favors the use of cemented implants. This technique is believed to be more stable in the immediate post-operative period, but there is limited evidence of a decreased morbidity and mortality with cemented versus press-fit stems (uncemented). In 2006, a meta-analysis concluded that the evidence was too limited to recommend a cemented or press-fit hemiarthroplasty.

In this investigation, the morbidity, mortality and functional outcome associated with cemented and press-fit hemiarthroplasty will be compared prospectively. We propose that the use of press-fit hemiarthroplasty in the treatment of displaced subcapital fractures of the femoral neck would be associated with a decreased risk of adverse peri-operative outcomes, and that the functional results of cemented and press-fit hemiarthroplasty will be equivalent at one year.

02

Conditions studied

  • Femoral Neck Fracture

Keywords

  • Hemiarthroplasty
  • Cemented
  • Press Fit
  • Mortality
  • Morbidity
  • Functional Status
  • Displaced femoral neck fracture
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 130 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Hartford Hospital is the lead sponsor of 101 studies on the registry; 19 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • older than 55 years
  • non-pathologic, displaced subcapital femoral neck fracture
  • designated for surgical reconstruction with a hemiarthroplasty by the attending surgeon
  • able to ambulate ten feet prior to presentation

Exclusion criteria

Exclusion Criteria:

  • unable to walk ten feet prior to hip fracture
  • multiple extremity trauma
  • pathologic fracture of the hip (including malignancy)
  • clinically recognized acute myocardial infarction within thirty days prior to enrollment
  • previously participated in the trial
  • symptoms associated with anemia
  • pre-existing metabolic bone disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Other
    Cemented Hip Hemiarthroplasty

    This arm received a hemiarthroplasty with a cemented femoral prosthesis (VerSys LD/Fx, Zimmer, Warsaw, IN).

    Device: Cemented Hip Hemiarthroplasty

  • Experimental
    Press-Fit Hip Hemiarthroplasty

    This arm received a press-fit hemiarthroplasty (VerSys Beaded FullCoat, Zimmer, Warsaw, IN),

    Device: VerSys Beaded FullCoat, Zimmer

Interventions

  • DeviceCemented Hip Hemiarthroplasty

    The cemented femoral prosthesis is a VerSys LD/Fx, Zimmer, Warsaw, IN.

  • DeviceVerSys Beaded FullCoat, Zimmer

    The press-fit component is a VerSys Beaded FullCoat, Zimmer, Warsaw, IN,

06

What researchers measure

Primary outcomes

  1. Mortality

    Assessment of post-operative mortality at one-year.

    Time frame: 1 year

  2. Post-Operative Unstable Angina

    Unstable angina was defined as the new onset of prolonged chest pain (greater than or equal to 30 minutes) or two episodes of chest pain thought to be of cardiac origin or an electrocardiogram showing new T-wave inversion, ST depression or elevation with enzymes non-diagnostic of myocardial ischemia.

    Time frame: 1 week post-operation

  3. Post-Operative Myocardial Infarction

    Myocardial infarction required a positive troponin or electrocardiogram consistent with definite infarction.

    Time frame: 1 week post-operation

Secondary outcomes

  1. Instrumental Activities of Daily Living (IADL) and Physical Activities of Daily Living (PADL) Scale

    A modified version of the Older Americans Resources and Services Instrument (OARS) which asks about performance of tasks of daily living during the preceding two weeks.14 These activities include: getting to places, walking distances, shopping for groceries or clothes, preparing meals and doing housecleaning.

    Time frame: 1 year

  2. Energy/Fatigue Scale

    An inquire about fatigue, level of energy and self-efficiency.

    Time frame: 1 year

07

Results

Posted Aug 7, 2018

Participant flow

Participant flow — Overall Study
MilestoneCemented Hip HemiarthroplastyPress-Fit Hip Hemiarthroplasty
Started6664
Completed6362
Not completed32
Withdrew: Withdrawal by subject32

Outcome measures

PrimaryMortality

Assessment of post-operative mortality at one-year.

Time frame:
1 year
Reported as:
Number · pecent
Mortality
pecentCemented Hip HemiarthroplastyPress-Fit Hip Hemiarthroplasty
Mortality23.120.1
PrimaryPost-Operative Unstable Angina

Unstable angina was defined as the new onset of prolonged chest pain (greater than or equal to 30 minutes) or two episodes of chest pain thought to be of cardiac origin or an electrocardiogram showing new T-wave inversion, ST depression or elevation with enzymes non-diagnostic of myocardial ischemia.

Time frame:
1 week post-operation

Results for this outcome have not been posted.

PrimaryPost-Operative Myocardial Infarction

Myocardial infarction required a positive troponin or electrocardiogram consistent with definite infarction.

Time frame:
1 week post-operation

Results for this outcome have not been posted.

SecondaryInstrumental Activities of Daily Living (IADL) and Physical Activities of Daily Living (PADL) Scale

A modified version of the Older Americans Resources and Services Instrument (OARS) which asks about performance of tasks of daily living during the preceding two weeks.14 These activities include: getting to places, walking distances, shopping for groceries or clothes, preparing meals and doing housecleaning.

Time frame:
1 year

Results for this outcome have not been posted.

SecondaryEnergy/Fatigue Scale

An inquire about fatigue, level of energy and self-efficiency.

Time frame:
1 year

Results for this outcome have not been posted.

Adverse events

Collected over Post-randomization unstable angina, MI during the index hospitalization or death for any reason within 30 days.. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cemented Hip Hemiarthroplasty—1/66 (1.5%)11/66 (16.7%)
Press-Fit Hip Hemiarthroplasty—1/64 (1.6%)8/64 (12.5%)
Most frequent serious events
Most frequent serious events
EventCemented Hip HemiarthroplastyPress-Fit Hip Hemiarthroplasty
DeathCardiac disorders1/661/64
Most frequent other events
Most frequent other events
EventCemented Hip HemiarthroplastyPress-Fit Hip Hemiarthroplasty
ICU stayGeneral disorders4/665/64
PneumoniaRespiratory, thoracic and mediastinal disorders3/661/64
Myocardial InfarctionCardiac disorders2/661/64
Wound InfectionInfections and infestations1/661/64
Re-operationSurgical and medical procedures1/660/64

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Cemented Hip HemiarthroplastyPress-Fit Hip HemiarthroplastyTotal
<=18 years000
Between 18 and 65 years000
>=65 years6664130
Age, Continuous
Age, Continuous(years)Cemented Hip HemiarthroplastyPress-Fit Hip HemiarthroplastyTotal
Mean81.8 ± 9.082.8 ± 7.682.3 ± 8.3
Sex: Female, Male
Sex: Female, Male(Participants)Cemented Hip HemiarthroplastyPress-Fit Hip HemiarthroplastyTotal
Female5248100
Male141630
Region of Enrollment
Region of Enrollment(participants)Cemented Hip HemiarthroplastyPress-Fit Hip HemiarthroplastyTotal
United States6664130
08

Study locations

1 site
  • Hartford Hospital
    Hartford, Connecticut 06106, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01114646
Lead sponsor
Hartford Hospital
Collaborators
Zimmer Biomet
Responsible party
Sponsor
First posted
May 3, 2010
Start date
Mar 2005
Primary completion
May 2009
Completion
May 2009
Results posted
Aug 7, 2018
Last update
Aug 7, 2018

Study contacts

Joseph P. DeAngelis, MD
study director · Hartford Hospital
Courtland G. Lewis, MD
principal investigator · Hartford Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion